4:持股变动声明-董事 Sternberg Perry J.
4:持股变动声明-董事 SILVERNAIL LAUREN P
4:持股变动声明-董事 Graves Adrienne L
4:持股变动声明-董事 Makary Martin A.
8-K:重大事件
10-Q:季度报表
8-K:哈罗公布2024年第一季度财务业绩
SC 13D/A:超过5%持股股东披露文件(修正)-Harrow, Inc.(0.0%)
DEFA14A:其他
DEF 14A:股东委托书决议
4:持股变动声明-股东 Opaleye Management Inc.
4:持股变动声明-股东 Opaleye Management Inc.
4:持股变动声明-股东 Opaleye Management Inc.
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 4:持股变动声明-股东 Opaleye Management Inc.
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 4:持股变动声明-高管 BAUM MARK L
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 4:持股变动声明-股东 Opaleye Management Inc.
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 8-K:重大事件
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 8-K:重大事件
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 10-K:年度报表
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 | 8-K:哈罗公布2023年第四季度和年终财务业绩
暂无数据